“Increased Serum Interleukin-17A Levels Correlate With Disease Severity and Poor Prognostic Factors in Patients With Alopecia Areata”. Dermatology Reports, vol. 14, no. 2, Oct. 2021, https://doi.org/10.4081/dr.2021.9398.